The following is a summary of “Combining Percentage Prostate-Specific Antigen Reduction and Multiparametric Magnetic ...

Artificial intelligence–derived tumor volume from baseline MRI and postprostatectomy outcomes following neoadjuvant hormonal therapy for patients with high-risk prostate cancer.

Too many men are dying of embarrassment, but there is a game-changer that could save both our lives and our blushes.

Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.

The PAIR-1 study shows that the Pi AI software, now in use in NHS and European hospitals, is the first commercial product of ...

But unless and until it is rolled out into the NHS, the most accurate test available is an MRI (magnetic resonance imaging) scan. Although I am symptom-free for prostate cancer, I am in my late ...

A 66-year-old male patient underwent surgery for prostate cancer 4 years ago. His initial prostate-specific antigen (PSA) ...

A new study investigates the utility of whole-body magnetic resonance imaging for detecting lymph and bone metastases in those with high-risk prostate cancer. Visit us on Facebook. Opens in a new ...

The following is a summary of “Computer-aided diagnosis based on 3D deep convolutional neural network system using novel 3D ...

A meta-analysis found that the use of magnetic resonance–guided daily ... with CT-guided non-adaptive SBRT in patients with prostate cancer. In an exploratory analysis, Hispanic men with primary ...

AcuityMD, the intelligence platform for the medical technology (MedTech) industry, has been selected by Profound Medical, a ...